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Treatment Failure of Tuberculosis due to Concomitant 
Pathology 
Z. A. Qasim,A. R. Sarwari,S. M. Jilani  ( Department of Medicine, Aga Khan University 
Hospital, Karachi. ) 
Introduction  
Tuberculosis is a worldwide problem. Nearly 3 million cases of tuberculosis occur per 
year in Southeast Asia alone.1 Several factors contribute to treatment failure and 
significant morbidity and mortality. While the most common causes in the "Third World" 
include poor compliance, late presentation, improper therapy, and the development of 
drug resistance2, underdiagnosis of this disease is an important reason in the West.3 We 
present two cases that demonstrate the importance of another factor, the impairment of 
the body's innate defense mechanism due to concomitant pathology, as a cause of 
treatment failure. 
Case Report  
Case 1 
A 19-year-old male was referred to the Infectious Diseases clinic for the evaluation of a 
progressively increasing neck swelling associated with persistent fever and pain. He was 
given anti-tuberculous therapy (ATT) at another hospital for tuberculous cervical 
lymphadenitis and Pott's disease of the lumbar vertebrae, which had caused a 
compression fracture with spinal cord impingement. According to the patient and his 
family, compliance with the drug regimen was good. 
Examination revealed a 15-centimeter firm, tender right cervical lymph node. Fine needle 
aspiration biopsy (FNAB) confirmed a chronic granulomatous process. A nine-month 
course of ATT (an initial 4-drug regimen consisting of isoniazid, rifampicin, ethambutol 
and pyrazinamide in doses appropriate for weight for 2 months, followed by a 
continuation phase of isoniazid and ethambutol) was completed with good compliance 
and symptomatic improvement, although he had several isolated recurrences of bacterial 
superinfection. 
Three months after completing his ATT, the patient returned with symptoms of fever, 
weight loss, and recurrence of his neck swellings. A chest CT showed mediastinal and 
axillary adenopathy. Diagnosed as having a relapse of his TB, he was restarted on the 
same regimen of ATT. The patient's condition worsened on subsequent follow-ups, and 
MRI revealed progressive adenopathy and the development of cord compression.  
The patient underwent surgical decompression of the spinal cord with concurrent 
vertebral bone biopsy and an excisional lymph node biopsy. Bone histopathology 
revealed a chronic granulomatous process (Figure 1) while the lymph node biopsy 
showed an effaced architecture, infiltrative inflammatory cells with predominant 
lymphocytes, as well as atypical cells (Figure 2). Immunophenotyping confirmed a T-cell 
rich B-cell non-Hodgkin's lymphoma. 
The final diagnosis was a stage IIIB non-Hodgkin's lymphoma with concomitant 
disseminated TB. The patient is currently continuing his ATT regimen and is receiving 
chemotherapy. 
Case 2 
A 62-year-old male presented to the Emergency Department with complaints of 
progressive dyspnea, fever, malaise, and weight loss almost a year after completing, with 
good compliance, anti-tuberculous therapy (an initial intensive phase of isoniazid, 
rifampicin, pyrazinamide and ethambutol in weight-appropriate doses for two months, 
followed by a continuation phase of isoniazid and ethambutol) for culture-proven, drug-
sensitive pulmonary tuberculosis. One and a half years earlier, he had suffered similar 
symptoms of dyspnea and dysphagia. A chest x-ray had revealed a cavitating apical lung 
lesion and mediastinal adenopathy. Fiberoptic bronchoscopy was performed. Culture of 
the bronchoalveolar lavage grew Mycobacterium tuberculosis, and the patient was treated 
with a 7-month course of anti-tuberculous therapy (an initial intensive phase of isoniazid, 
rifampicin, pyrazinamide, ethambutol, and streptomycin, followed by a continuation 
phase of isoniazid, rifampicin, and ethambutol). Subjective clinical improvement in 
symptoms and radiological evidence of disease regression was documented. 
A chest X-ray taken for his current complaints revealed relapse of mediastinal along with 
left-sided atelectasis secondary to left mainstem bronchial compression. In light of his 
past medical history, he was admitted with the provisional diagnosis of mediastinal TB 
lymphadenitis resistant to first-line therapy. During his hospital admission, he suffered a 
respiratory arrest secondary to tracheal compression. The patient was emergently 
intubated and transferred to the intensive-care unit. Once stabilized, an excision biopsy of 
the right supraclavicular node was undertaken. The histopathology showed diffuse small 
cleaved cell (mantle cell) non-Hodgkin's lymphoma. In addition, culture of the lymph 
node material grew Mycobacterium tuberculosis. 
The patient's final diagnosis was non-Hodgkin's lymphoma with concurrent tuberculous 
lymphadenitis. He has to date received three courses of chemotherapy for his lymphoma 
and restarted ATT. 
Discussion 
Tuberculosis is caused by Mycobacterium tuberculosis, an aerobic, non-spore-forming, 
acid-fast bacillus that is transmitted by aerosolized droplets. Within the body, these 
bacilli are ingested by macrophages and either die or proliferate. An effective immune 
response is only achieved after widespread blood or lymphatic spread has occurred.3 The 
bacilli are walled off by granulomatous inflammation, and some bacilli persist in these 
granulomas. This stage is known as primary tuberculosis, and is often asymptomatic. 
Post-primary tuberculosis manifests as a systemic illness, and occurs due to reactivation 
of a primary focus, or exogenous reinfection4, either in the lung or in an extrapulmonary 
site. Central to the effective control of tuberculosis is the body's cell-mediated immune 
system, which aborts 90-95% of infections. Symptomatic tuberculosis occurs in only 5-
10% of infected individuals.3 Anti-tuberculous therapy acts to augment the host's 
immune response and does not, by itself, effect a cure.  
Intact cell-mediated immunity can be demonstrated by a positive Mantoux skin test. 
Suppression of cell-mediated immunity would promote symptomatic disease, as is 
evidenced by the increasing incidence of tuberculosis in the1980s, paralleling the rise in 
the incidence of HIV infection.5 Alterations in cell-mediated immunity should always be 
considered as a cause of treatment failure. 
A primary malignancy such as lymphoma may cause suppression of cell-mediated 
immunity. It is important to recognize that tuberculosis of the lymph node may occur as a 
result of this disturbance, with the concomitant presentation of both pathologies.6-8 The 
incidence of TB lymphadenitis in lymphoma patients is much higher than in the patients 
without a malignancy8 and the presence of TB may be the main factor contributing to the 
death of the patient.9 Some studies suggest that the chronic inflammation of TB 
lymphadenitis may actually precede and accelerate the onset of the lymphoma.6,7 It is 
interesting to note that one study found the incidence of disseminated tuberculosis to be 
more common in non-Hodgkin's lymphoma as compared to Hodgkin's disease.8 Both of 
our patients suffered from non-Hodgkin's lymphoma. Geographic location also appears to 
have an impact on the concurrent appearance of both pathologies10,11, the association 
being higher in high-prevalence areas of TB.  
The prevalence of both individual diseases in Pakistan is high. According to one study, 
lymphoma ranks closely behind lung cancer as one of the most common malignancies 
encountered.12 In contrast to the Western literature, the incidence of this malignancy is 
higher in males.12 As mentioned before, tuberculosis is also endemic in Pakistan1 and it 
is among the differential diagnoses of a variety of clinical presentations. The clinical 
presentation of the two diseases is similar, thus presenting a diagnostic challenge. The 
patient with either disease can complain of progressive lymphadenopathy with 
constitutional symptoms of low-grade fever and weight loss. The presence of both 
diseases at the same time could thus be masked by symptoms suggestive of one or the 
other. When the clinical presentation fails to differentiate between them, other 
noninvasive and invasive methods are of use. 
Imaging modalities show some promise in helping to differentiate tuberculosis from 
lymphoma. Yang et al support the use of contrast-enhanced CT as being a viable 
option.13 Their study shows that patients with tuberculosis (nondisseminated and 
disseminated) had mesenteric nodal involvement whereas those with Hodgkin's disease 
did not show this pattern. In addition, lower para-aortic nodes were more often involved 
in lymphoma than in nondisseminated tuberculosis. The anatomic involvement was not 
significant, however, in the comparison of patients with disseminated TB and non-
Hodgkin's lymphoma. In patients with tuberculosis, peripheral enhancement of the 
involved nodes was the rule, whereas the majority of lymphoma patients showed a 
homogenous nodal enhancement.  
A definitive diagnosis can only be achieved by positive cultures, with histopathology9,14 
providing supporting evidence. In obtaining biopsy specimens, pitfalls of FNAB must be 
realized, especially when a lymphoproliferative disorder is in the differential. Performing 
excisional or incisional lymph node biopsy is preferred when lymphoma is suspected, as 
the characteristic histopathologic features of both disease processes can be easily 
delineated by this method. In view of the delay in diagnosis of the concomitant 
pathologies in both of our cases, and because of the high prevalence of TB and 
lymphoma in Pakistan, we would recommend early evaluation of the lymph nodes by 
excision biopsy to obtain a tissue and microbiologic diagnosis and therefore allow 
optimum treatment. However, the significant morbidity associated with any invasive 
procedure, especially laparotomy for the retrieval of an abdominal node, lends further 
weight to trying to find a noninvasive method with sufficient sensitivity and specificity 
that may become a routine and cost-effective diagnostic tool. 
These cases demonstrate that treatment failure of extrapulmonary TB in a previously 
healthy patient should prompt investigation into finding common as well as uncommon 
causes, including concurrent pathology. Both lymphoma and tuberculosis show a high 
prevalence in Pakistan, with the published literature showing an association between the 
two. Reduction in morbidity and mortality can only be achieved if there is an awareness 
of this phenomenon and a low index of suspicion, leading to early diagnosis and 
simultaneous treatment of both pathologies. 
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